Text Omitted and Filed Separately Confidential Treatment Requested Under 17 C.F.R. (S)(S) 200.80(b)(4), 200.83 and 240.24b-2 COLLABORATIVE DEVELOPMENT AND MARKETING AGREEMENT Collaborative Development and Marketing Agreement TABLE OF CONTENTS...Collaborative Development and Marketing Agreement • November 12th, 2002 • Dendreon Corp • Pharmaceutical preparations • New York
EQUITY INVESTMENT AGREEMENTEquity Investment Agreement • November 12th, 2002 • Dendreon Corp • Pharmaceutical preparations
THIS EQUITY INVESTMENT AGREEMENT (the “Agreement”) is made as of July 31, 2002, by and between DENDREON CORPORATION, a Delaware corporation (the “Company”), and GENENTECH, INC., a Delaware corporation (the “Purchaser”).
